Related Experiment Videos
In the prostatic epithelium, dietary isoflavones from red clover significantly increase estrogen receptor beta and
1Institute for Biomedical Research, The University of Sydney, Australia. michaels@anatomy.usyd.edu.au
Prostate Cancer and Prostatic Diseases
|June 15, 2004
Summary
Red clover isoflavones may offer a safe dietary approach for benign prostatic hyperplasia. This nutritional intervention in mice showed potential for reducing prostate cancer risk by influencing key cellular markers.
Area of Science:
- Biochemistry
- Oncology
- Endocrinology
Background:
- Benign prostatic hyperplasia (BPH) is a common condition in aging men.
- Estrogenic pathways play a role in prostate health and disease.
- Dietary compounds like isoflavones are being investigated for their therapeutic potential.
Purpose of the Study:
- To investigate the effects of red clover isoflavones on the prostate.
- To assess the impact of isoflavones on markers of proliferation and neoplastic transformation.
Main Methods:
- Mice were fed a diet supplemented with red clover isoflavones.
- Prostatic tissues were analyzed for changes in estrogen receptor beta (ERβ), E-cadherin, and transforming growth factor beta1 (TGF-β1) expression.
Main Results:
- Red clover isoflavones significantly increased ERβ and E-cadherin production in the prostatic epithelium.
- A decrease in TGF-β1 was observed.
- These changes indicate enhanced cell proliferation, maintained tissue structure, and reduced potential for cancer development.
Conclusions:
- Red clover isoflavones show promise as a non-toxic dietary treatment for BPH.
- This dietary intervention may reduce the risk of neoplastic and metastatic transformation in the prostate.